TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years
The Global Alliance for TB Drug Development (TB Alliance) has...
Vice-Chancellor of Igbinedion University, Okada, Prof. Lawrence Ezemonye, on Thursday, March 26, 2026, raised concerns over accelerating global deforestation,...